Ahmad Jamal, Pathan Md Faruque, Jaleel Mohammed Abdul, Fathima Farah Naaz, Raza Syed Abbas, Khan A K Azad, Ishtiaq Osama, Sheikh Aisha
Rajiv Gandhi Centre for Diabetes and Endocrinology, J. N. Medical College, Aligarh Muslim University, Aligarh, India.
Indian J Endocrinol Metab. 2012 Jul;16(4):512-5. doi: 10.4103/2230-8210.97996.
Majority of physicians are of the opinion that Ramadan fasting is acceptable for well-balanced type 2 patients conscious of their disease and compliant with their diet and drug intake. Fasting during Ramadan for patients with diabetes carries a risk of an assortment of complications. Islamic rules allow patients not to fast. However, if patient with diabetes wish to fast, it is necessary to advice them to undertake regular monitoring of blood glucose levels several times a day, to reduce the risk of hypoglycemia during day time fasting or hyperglycemia during the night. Patient with type 1 diabetes who fast during Ramadan may be better managed with fast-acting insulin. They should have basic knowledge of carbohydrate metabolism, the standard principles of diabetes care, and pharmacology of various antidiabetic drugs. This Consensus Statement describes the management of the various diabetic emergencies that may occur during Ramadan.
大多数医生认为,斋月禁食对于病情稳定、了解自身疾病且能遵循饮食和药物摄入规定的2型糖尿病患者是可以接受的。糖尿病患者在斋月期间禁食会有一系列并发症的风险。伊斯兰教规允许患者不禁食。然而,如果糖尿病患者希望禁食,有必要建议他们每天多次定期监测血糖水平,以降低白天禁食期间低血糖或夜间高血糖的风险。斋月期间禁食的1型糖尿病患者使用速效胰岛素可能会得到更好的治疗。他们应该具备碳水化合物代谢的基本知识、糖尿病护理的标准原则以及各种抗糖尿病药物的药理学知识。本共识声明描述了斋月期间可能发生的各种糖尿病急症的管理方法。